High dose of JCM-16021 treatment did not show any effect on the decreased SERT expression in PI-IBS rats, indicating that JCM-16021 treatment can decrease colonic EC cell number, 5-HT content, and TPH expression, but not SERT expression, in PI-IBS rats. Here, SLC6A4 is linked to irritable bowel syndrome.